Home Mylan targets Perrigo shareholders in latest generics mega-merger attempt
 

Keywords :   


Mylan targets Perrigo shareholders in latest generics mega-merger attempt

2015-09-14 23:16:14| Biotech - Topix.net

Mylan has been looking to acquire generics and OTC drugmaker Perrigo since it launched a hostile bid in April . Last week Mylan said in a letter "shareholders will receive $75 per share in cash, and own approximately 40% of the new powerhouse company created by the combination," and today has formalised this offer, which values Perrigo at just over $27bn .

Tags: latest attempt targets shareholders

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.11PM responds to Sir Alan Bates after repeated requests
05.11American Angus elects 2024-25 board leaders
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Public Advisory Number 8A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Brazil gives green light to medicinal use of Cannabis in animals
More »